US Bancorp DE Has $694,000 Stock Position in Bruker Co. (NASDAQ:BRKR)

US Bancorp DE cut its position in shares of Bruker Co. (NASDAQ:BRKR) by 6.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,833 shares of the medical research company’s stock after selling 867 shares during the period. US Bancorp DE’s holdings in Bruker were worth $694,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of BRKR. Assetmark Inc. raised its stake in shares of Bruker by 23.7% in the 3rd quarter. Assetmark Inc. now owns 1,729 shares of the medical research company’s stock valued at $119,000 after buying an additional 331 shares in the last quarter. Atria Investments Inc increased its stake in Bruker by 4.4% in the third quarter. Atria Investments Inc now owns 12,698 shares of the medical research company’s stock valued at $877,000 after acquiring an additional 538 shares during the period. State of New Jersey Common Pension Fund D raised its position in Bruker by 3.6% in the third quarter. State of New Jersey Common Pension Fund D now owns 36,627 shares of the medical research company’s stock worth $2,529,000 after purchasing an additional 1,267 shares in the last quarter. Aptus Capital Advisors LLC lifted its stake in Bruker by 15.8% during the third quarter. Aptus Capital Advisors LLC now owns 40,522 shares of the medical research company’s stock worth $2,798,000 after purchasing an additional 5,523 shares during the period. Finally, KBC Group NV boosted its holdings in Bruker by 1.8% during the third quarter. KBC Group NV now owns 42,680 shares of the medical research company’s stock valued at $2,947,000 after purchasing an additional 763 shares in the last quarter. 79.52% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

BRKR has been the subject of several analyst reports. UBS Group initiated coverage on Bruker in a research report on Tuesday, December 10th. They set a “neutral” rating and a $66.00 target price for the company. Bank of America lifted their price objective on Bruker from $78.00 to $80.00 and gave the company a “buy” rating in a report on Friday, December 13th. Barclays lowered their target price on shares of Bruker from $69.00 to $65.00 and set an “overweight” rating on the stock in a report on Monday, February 10th. Stifel Nicolaus cut their price target on shares of Bruker from $70.00 to $57.00 and set a “hold” rating for the company in a report on Friday, February 14th. Finally, The Goldman Sachs Group raised shares of Bruker from a “sell” rating to a “neutral” rating and set a $60.00 price objective on the stock in a research note on Thursday, December 5th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $70.50.

Bruker Price Performance

Shares of BRKR stock opened at $47.40 on Tuesday. The firm has a market cap of $7.19 billion, a price-to-earnings ratio of 62.37, a PEG ratio of 2.16 and a beta of 1.18. Bruker Co. has a 12 month low of $45.29 and a 12 month high of $94.86. The company has a quick ratio of 0.77, a current ratio of 1.60 and a debt-to-equity ratio of 1.15. The stock has a 50-day moving average price of $54.97 and a 200 day moving average price of $59.00.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings results on Thursday, February 13th. The medical research company reported $0.76 EPS for the quarter, topping the consensus estimate of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. Research analysts expect that Bruker Co. will post 2.69 EPS for the current year.

Bruker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, March 28th. Stockholders of record on Monday, March 17th will be paid a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.42%. The ex-dividend date of this dividend is Monday, March 17th. Bruker’s dividend payout ratio (DPR) is currently 26.32%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.